 |
| Eye ball to eye ball with DeepMind. |
DeepMind, the brainy bunch of British boffins whom Google pickedup to carry forward the AI torch, has reported in a scientific journal that it succeeded in employing a common ophthalmological tests to screen for many health disorders.
So reports Bloomberg.
DeepMind’s software used two separate neural networks, a kind of machine learning loosely based on how the human brain works. One neural network labels features in OCT images associated with eye diseases, while the other diagnoses eye conditions based on these features.
Splitting the task means that -- unlike an individual network that makes diagnoses directly from medical imagery – DeepMind’s AI isn’t a black box whose decision-making rationale is completely opaque to human doctors, [a principal said].
The group, which encountered controversy over its use of patient data in the past, said it has cleared important hurdles and hopes to move to clinical tests in 2019.
Related
https://www.bloomberg.com/news/articles/2018-08-13/google-s-deepmind-to-create-product-to-spot-sight-threatening-disease
No comments:
Post a Comment